I subscribe to Google Alerts — a service, from Google, that sends me a weekly email with new or updated search results for the search term that I have selected. The only alert that I have set up is “Schellack” (please forgive the obvious egocentric-ness here).

It’s always interesting to see where a Schellack shows up — especially when it’s not in German, since I can’t read German.

Here’s the most recent example: IC31, a novel adjuvant signaling via TLR9, induces potent cellular …

How cool is that? Someone named Carola Schellack was the lead in an Austrian study of a vaccine in mice (IC31), the “combination of a novel immunostimulatory oligodeoxynucleotide containing deoxy-Inosine/deoxy-Cytosine (ODN1a) and the antimicrobial peptide KLKL(5)KLK.”

Don’t worry; I didn’t really understand that either (it’s something that stimulates the immune system — maybe a cure for HIV/AIDS!), but you must admit that other Schellacks are doing great work out there!